Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (674)

« Back to Publications

The low-density lipoprotein receptor LDLR mediates cellular entry of nonenveloped hepatitis A virus.

Shiota T. et al, (2026), Proceedings of the National Academy of Sciences of the United States of America, 123

Cattle antibodies identify a cross-serotype broadly neutralising foot-and-mouth disease virus epitope.

Bonnet-Di Placido M. et al, (2026), NPJ vaccines

Amino acid and viral binding by the high-affinity Cationic Amino acid Transporter 1 (CAT1) from Mus musculus

Ye M. et al, (2026), Nature Communications, 17

The cumulative incidence and infection hospitalization risk of SARS-CoV-2 by variant: a longitudinal study in England

Gaughan C. et al, (2026), American Journal of Epidemiology, 195, 188 - 197

Capsid restructuring activates semi-conservative dsRNA transcription in cystovirus ɸ6.

Ilca SL. et al, (2026), Molecular cell, 86, 289 - 303.e5

Electron fourier ptychography for phase reconstruction

Zhao J. et al, (2025), Scientific Reports, 15

Capsid Restructuring Activates Semi-Conservative dsRNA Transcription in Cystovirus ɸ6.

Ilca SL. et al, (2025), bioRxiv

Author Correction: An RBD-Fc mucosal vaccine provides variant-proof protection against SARS-CoV-2 in mice and hamsters.

Zhang Y. et al, (2025), NPJ vaccines, 10

Identification of undetected SARS-CoV-2 infections by clustering of Nucleocapsid antibody trajectories

Zwerwer LR. et al, (2025), Nature Communications, 16

An RBD-Fc mucosal vaccine provides variant-proof protection against SARS-CoV-2 in mice and hamsters.

Zhang Y. et al, (2025), NPJ vaccines, 10

Temporal correlations between RBD-ACE2 blocking and binding antibodies to SARS-CoV-2 variants in CoronaVac-vaccinated individuals and their persistence in COVID-19 patients.

Poolchanuan P. et al, (2025), Scientific reports, 15

Production of an immunogenic trivalent poliovirus virus-like particle vaccine candidate in yeast using controlled fermentation.

Sherry L. et al, (2025), NPJ vaccines, 10

TomoCPT: a generalizable model for 3D particle detection and localization in cryo-electron tomograms

Shah PNM. et al, (2025), Acta Crystallographica Section D Structural Biology, 81, 63 - 76

Monkeypox virus isolation from longitudinal samples in 11 hospitalised patients

Callaby H. et al, (2025), The Lancet Infectious Diseases, 25, e4 - e5

Recombinant expression systems for production of stabilised virus-like particles as next-generation polio vaccines.

Sherry L. et al, (2025), Nature communications, 16

Load More

1
2
3
4
5
6
7
...
»